On June 23, 2021, Dr. Jin Lei, Chief Operating Officer of BioAurora Biosciences (Wuxi) Co., Ltd., and a delegation of three other members visited the School of Life Sciences for exchange activities. The two sides conducted in-depth discussions on scientific research cooperation and talent training, deepened mutual understanding, and further established a university-enterprise cooperation platform.
Founded by Shuangliang Group (one of China’s Top 500 Enterprises) together with multiple overseas returnee scientists with working experience in international pharmaceutical companies, BioAurora Biosciences (Wuxi) Co., Ltd. was established in 2009. The company is dedicated to providing early-stage drug discovery CRO services for global innovative pharmaceutical R&D institutions. Its services are built on complex protein preparation and underpinned by structural biology as core competitiveness. The enterprise promotes Structure-Based Drug Discovery (SBDD) and strives to build an internationally renowned brand in the field of structural biology.
